A

Advaxis, Inc.

44 employees

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

Basic info

biotechnology research

Biotechnology

Pharmaceutical

Anal Cancer

Prostate Cancer

Health Diagnostics

HPV

Oncology

Personalized Medicine

Head and Neck Cancer

Infectious Disease

Immunotherapy

Cervical Cancer

Microcap

2002

$23M

from 3 investors over 3 rounds

A

Advaxis, Inc. raised $23M on February 19, 2015

Investors: Sectoral Asset Management, Adage Capital Management and T. Rowe Price